Factor Xa inhibitor vs. aspirin in extended phase of prevention recurrent VTE
Educational information
This video was recorded during ACC 2017, March 17-19 in Washington, DC, USA. PACE-cme did not receive financial support for the production of this video.
The educational content reflects the personal opinion of the expert.
Disclosures
Dr. Philip Wells - University of Ottawa, ONT, Canada
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: